Member Info for toptiger

just seen new presentation on youtube, seems 3 days old, only 21 views sadly....but are reneuron ramping up ?

some strange trade prices going through making it hard to know what is going on and all of a sudden.......its back in play it seems.

and when this goes........

PC01,

can be corrected but think its every whole % cleared on way up and down until below 3%

so should have notified if below his recent 33 odd percent.

in for some, wanted these for a while but have a large ish stake for me in africa oil but want a bit more juice in this so bought 3k

cant see an awful lot of downside and from my experience of watching oil for years, this tends to get better / upgraded post discoveries....

Rene_to_40p,

correct on the youtube link about "tossing it", however would you run such long trials if it wasnt going anywhere? No you wouldnt. If your partner was "no good" i'm sure they would be kicked to the kerb ?

is this also woodford knocking it down from 240p again ? any thoughts ?

i'm sure rene need positive news flow (or just some newsflow) so for now the retina program is centre stage however they always recount each area very matter of factly.

And it is only a slight delay......

As always rene to 40p bit over dramatic, I can never work if your a holder or not

cadbury,

is that really that well read ?

i think rns early next week, and as someone said, if tomorrow, thats one hell of a blatant.......piece of leaking

my guess is smallish but significant to us, exosome deal

Agreed Chester this isn't normal Rene behaviour

In fact very steady buying which it has only really done on or after news

Agreed pc, 3k sells dried up lately and steady small buying moves this.

Something brewing ?

write up of woodfords bio stocks in evening standard, we are mentioned of the 3 that have done well!

amazing really how we escaped really, and i'm convinced we have. When you see the stuff that has gone on in the other companies......gosh.

Obviously they know what the next results will be, of new cohort and existing cohorts started a while back.

So....on wrap up of next cohort, in October, these people will be required and add weight to the results conclusions as well as being heavyweights to deal with the FDA on potential commercialisation, assuming they are leaders in their field.

seems to me reneuron are preparing the next steps.......

dont really like the "market best quote at 2.15 for only 1000 shares, already hold 8000 which for me is ok as its still a risky biotech (well it isnt really but have to put that in).

Mostly in cash these days with frequent centamin day trades.

hows that for a balanced portfolio? centamin and reneuron plus a few other bits and pieces (like africa oil)

woodford would be proud ! :-)

Well it's join the dots time, these people wouldn't be needed if no product and they wouldn't accept if they weren't fairly sure either.

This plus the new guy in charge of deals can really only mean one thing

ridiculous potential !! :-)

just about to say same thing, decent sized trades as well...

agreed PC01,

you could attack rene if you assumed they would need a rights issue to take RP product to mkt or if they needed more time to prove effects etc but that would mean the shorter was really clued into the trials process and its not as if rene have not been transparent on time scales / funding.

other than that.....cant see what angle they would take, though based on the shorting taerget description, we are a candidate in theory.

finally, the justification for shorting was based on woodford being a forced seller, which in theory with us he isnt because just too small, either way if his fate is decided we wont make a difference either way.....